Pharmsville Statistics

Total Valuation

Pharmsville has a market cap or net worth of KRW 30.49 billion. The enterprise value is -8.09 billion.

Market Cap	30.49B
Enterprise Value	-8.09B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Pharmsville has 7.73 million shares outstanding. The number of shares has decreased by -1.07% in one year.

Current Share Class	n/a
Shares Outstanding	7.73M
Shares Change (YoY)	-1.07%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	80.39%
Owned by Institutions (%)	n/a
Float	1.52M

Valuation Ratios

The trailing PE ratio is 33.20.

PE Ratio	33.20
Forward PE	n/a
PS Ratio	1.71
PB Ratio	0.48
P/TBV Ratio	0.48
P/FCF Ratio	13.42
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.77
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.56

Financial Position

The company has a current ratio of 11.27, with a Debt / Equity ratio of 0.01.

Current Ratio	11.27
Quick Ratio	10.56
Debt / Equity	0.01
Debt / EBITDA	225.30
Debt / FCF	0.25
Interest Coverage	-17.06

Financial Efficiency

Return on equity (ROE) is 1.44% and return on invested capital (ROIC) is -0.98%.

Return on Equity (ROE)	1.44%
Return on Assets (ROA)	-0.91%
Return on Capital (ROIC)	-0.98%
Revenue Per Employee	543.12M
Profits Per Employee	27.93M
Employee Count	33
Asset Turnover	0.25
Inventory Turnover	2.71

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.71% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-54.71%
50-Day Moving Average	4,760.50
200-Day Moving Average	5,829.45
Relative Strength Index (RSI)	43.20
Average Volume (20 Days)	81,662

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharmsville had revenue of KRW 17.92 billion and earned 921.79 million in profits. Earnings per share was 118.84.

Revenue	17.92B
Gross Profit	10.96B
Operating Income	-1.03B
Pretax Income	1.21B
Net Income	921.79M
EBITDA	2.54M
EBIT	-1.03B
Earnings Per Share (EPS)	118.84

Full Income Statement

Balance Sheet

The company has 39.25 billion in cash and 571.25 million in debt, giving a net cash position of 38.67 billion or 5,004.33 per share.

Cash & Cash Equivalents	39.25B
Total Debt	571.25M
Net Cash	38.67B
Net Cash Per Share	5,004.33
Equity (Book Value)	63.69B
Book Value Per Share	8,228.36
Working Capital	39.46B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.29 billion and capital expenditures -17.84 million, giving a free cash flow of 2.27 billion.

Operating Cash Flow	2.29B
Capital Expenditures	-17.84M
Free Cash Flow	2.27B
FCF Per Share	293.89

Full Cash Flow Statement

Margins

Gross margin is 61.17%, with operating and profit margins of -5.76% and 5.14%.

Gross Margin	61.17%
Operating Margin	-5.76%
Pretax Margin	6.77%
Profit Margin	5.14%
EBITDA Margin	0.01%
EBIT Margin	-5.76%
FCF Margin	12.67%

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 2.53%.

Dividend Per Share	100.00
Dividend Yield	2.53%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	84.07%
Buyback Yield	1.07%
Shareholder Yield	3.61%
Earnings Yield	3.01%
FCF Yield	7.45%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pharmsville has an Altman Z-Score of 7.36.

Altman Z-Score	7.36
Piotroski F-Score	n/a